Morphea and other localized forms of scleroderma

Rebecca Vasquez, Chelsea Sendejo, Heidi Jacobe

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations


Purpose of Review: Morphea, also known as localized scleroderma, is a disorder of excessive collagen deposition leading to thickening of the dermis and/or subcutaneous tissues and may cause significant morbidity. This review will describe new developments in the evaluation and management of morphea as well as its pathophysiology. The reader will be able to apply these findings to patient management. Recent Findings: The recent development of validated outcome measures (i.e. the localized scleroderma cutaneous assessment tool) as well as consensus treatment recommendations provide a platform for collaboration among specialties to develop both standardized assessment tools and therapeutic trials. New studies have also begun to investigate the immunological underpinnings of morphea. Summary: The promise of evidence-based treatments for morphea in the near future will provide better care for patients with morphea and understanding its pathophysiology will lay groundwork for the development of new treatments.

Original languageEnglish (US)
Pages (from-to)685-693
Number of pages9
JournalCurrent Opinion in Rheumatology
Issue number6
StatePublished - Nov 2012


  • localized scleroderma
  • morphea
  • outcome measures
  • treatment

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'Morphea and other localized forms of scleroderma'. Together they form a unique fingerprint.

Cite this